IMS and Innovex announce UK alliance

February 17, 2005
Sales and Marketing

Pharma data consultants IMS have announced a new alliance with contract sales provider Innovex to supply its field forces with …

ADHD latest drugs to be hit by safety warnings

February 17, 2005
Sales and Marketing

Attention deficit hyperactivity disorder (ADHD) treatments are the latest class of drugs to be hit by safety warnings, with regulators …

New FDA drug safety board to be more independent

February 17, 2005
Sales and Marketing

A new independent FDA board will be set up to monitor drug safety and issue warnings to doctors and patients …

New customers: new education

February 16, 2005

Doctors have for a long time been the primary influencers of prescribing and chronic disease management. For pharma companies, that …

NHS to be key election issue as Blair unveils pledge

February 15, 2005
Blair, NHS

 Tony Blair has signalled Labour’s record on the NHS will be one of the key issues on which it will …

Chronic disease programme needs more work, says think tank

February 14, 2005

The new system of chronic disease management currently being piloted in ten PCTs needs further evaluation before it is extended …

New UK biotech fundraising initiative declared a win-win

February 10, 2005
Research and Development

Current rules which restrict how companies raise cash should be interpreted more freely to help UK biotech and other hi-tech …

Roche hepatitis and HIV combination approved

February 9, 2005
Sales and Marketing

Roche's Pegasys has become the first treatment licensed for patients suffering hepatitis C and HIV at the same time.The European …

Sanofi-Aventis sponsor cardiovascular research centre

February 9, 2005
Sales and Marketing

A new UK centre specialising in research into cardiovascular disease has opened its doors at St Mary's Hospital in Paddington, …

Schering launches new dermatology company

February 8, 2005
Sales and Marketing

German pharma company Schering has created a new, independent group, Intendis, focused on developing and marketing dermatology products.Intendis' new management …

Audit service launched to judge pharma marketing success

February 8, 2005

Marketing consultants Q2 Audit have launched a service to measure pharma's marketing effectiveness and give an indication of future product …

Rare side-effect warnings for Strattera

February 8, 2005
Sales and Marketing

UK health professionals have been warned  about rare but serious liver problems observed in Lilly's Strattera.The drug has been licensed …

Connecting with patients

February 8, 2005
Medical Communications

In order for a clinical trial to be viable, it needs patients. Sounds obvious, but despite the fact that patients …

New depression treatment launched in the UK

February 3, 2005
Sales and Marketing

Lilly and Boehringer Ingelheim's depression treatment Cymbalta has been launched in the UK where it will do battle in the …

New ‘economic damage’ offence to beat animal activists

February 3, 2005
Sales and Marketing

The government has unveiled new laws to counteract the intimidation tactics used by activists to undermine animal research. Animal rights …

‘Smarter steroid’ Alvesco launched in the UK

February 3, 2005
Sales and Marketing

Alvesco, the first one puff, once-daily inhaled corticosteroid for asthma has been launched in the UK, its first European market.Manufacturers …

The Gateway to Local Adoption Series

Latest content